tirzepatide vs glp-1 Semaglutide: Which Medication is Better? comparing cardiovascular and kidney outcomes

Comprehensive labs come first

Silver Spring: FDA

Secondary, safety and negative control endpoints For individual components of the primary endpoint, semaglutide versus sitagliptin reduced myocardial infarction (HR 0.81, 95% CI 0.70 to 0.92) and stroke (HR 0.84, 95% CI 0.71 to 0.99) in the expanded populations at low, moderate and high cardiovascular risk

Over 18 months, compounded semaglutide saves approximately $2,400 compared to cash-pay brand-name Ozempic

These injectionsand, now, pillshave reshaped how medicine thinks about obesity and diabetes, as well as helped usher in a new era of hyperskinny celebrities and models

doi: 10.1016/j.cbi.2023.110684